Company Filing History:
Years Active: 2010
Title: Hisahide Hiura: Innovator in Antibody Development
Introduction
Hisahide Hiura is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of antibodies for medical applications. His work focuses on measuring ADAMTS13 activity, which is crucial for understanding various blood disorders.
Latest Patents
Hisahide Hiura holds a patent for an "Antibody for assaying ADAMTS13 activity and method for assaying the activity." This invention provides a useful monoclonal antibody specifically designed to measure ADAMTS13 activity. The antibody demonstrates specific reactivity to an antigenic determinant site produced by the interaction of ADAMTS13 with von Willebrand factor (VWF), a substrate involved in blood clotting. This innovation is vital for advancing diagnostic methods in hematology.
Career Highlights
Hiura is associated with Alfresa Pharma Corporation, where he continues to contribute to research and development in the pharmaceutical industry. His expertise in antibody development has positioned him as a key figure in his field. His work not only enhances diagnostic capabilities but also paves the way for potential therapeutic applications.
Collaborations
Hiura has collaborated with notable colleagues such as Seiji Kato and Yoshihiro Fujimura. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the realm of biochemistry.
Conclusion
Hisahide Hiura's contributions to the development of antibodies for measuring ADAMTS13 activity highlight his importance as an inventor in the field of biochemistry. His work has the potential to significantly impact medical diagnostics and treatment strategies.